Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.
about
Effects of different cyclodextrins on the morphology, loading and release properties of poly (DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolamAffinity-Based Drug DeliveryFirst principles insight into the alpha-glucan structures of starch: their synthesis, conformation, and hydration.Cyclodextrins in delivery systems: ApplicationsAdvances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels.Monitoring model drug microencapsulation in PLGA scaffolds using X-ray powder diffraction.Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium.PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).Preparation of Fluconazole β-Cyclodextrin Complex Ocuserts: In Vitro and In Vivo Evaluation.Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death.Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery.Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.Physicochemical properties and dissolution studies of dexamethasone acetate-beta-cyclodextrin inclusion complexes produced by different methods.Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen deliveryThermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse.Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine.Sorption of agrochemical model compounds by sorbent materials containing beta-cyclodextrin.Carbopol-based gels for nasal delivery of progesterone.Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin.Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose.Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol.Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.Role of cellulose ether polymers on ibuprofen release from matrix tablets.β-Cyclodextrin- and adamantyl-substituted poly(acrylate) self-assembling aqueous networks designed for controlled complexation and release of small molecules.Scalable single-step microfluidic production of single-core double emulsions with ultra-thin shells.Pharmacokinetic analysis and optimization of hydroxycamptothecin-loaded nanoparticles for liver targeting.Chlorhexidine Loaded Cyclodextrin Containing PMMA Nanogels as Antimicrobial Coating and Delivery Systems.β-Cyclodextrin hydrogel incorporating hydrophobically modified poly(N-isopropylacrylamide) for a temperature-dependent releaseControlled delivery of dexamethasone to the intestine from poly(vinyl alcohol)–poly(acrylic acid) microspheres containing drug-cyclodextrin complexes: influence of method of preparation of inclusion complexCyclodextrin modified hydrogels of PVP/PEG for sustained drug releaseCyclodextrin Controlled Release of Poorly Water-Soluble Drugs from HydrogelsEffect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer
P2860
Q28299123-98F032C3-FD99-4EEE-A19F-15569ADD093DQ29543246-B6655F15-D3C7-4263-8918-F8118D4C7015Q33788978-B3D4947E-5CA9-48F7-A20B-49459CDCAB34Q35138039-8EC7261F-BF80-4FD2-90DA-872A59EFF6CFQ36548827-A95160F3-D2E4-4D46-A261-C177298835EDQ36748033-0DC04F1A-4264-4F07-AE92-3DC730F1DB48Q36917923-B98637C9-0BEA-4753-968B-411485752B36Q37610470-46A83AFA-3F98-4334-8139-C77E44817539Q39021288-6B935E88-598B-47C6-9A05-15F10A196775Q39338573-E962D0EF-D6F3-4628-9D86-6824B7670678Q39533415-A2491378-FC7C-46BA-835F-BCAD333921ABQ40586018-6FFA2253-5BDC-45B9-9337-C352E2513F7FQ41359733-32775702-2CC9-44F9-B190-9C731B54D75DQ41843480-6845DA55-F763-4304-8AF0-B65F734A2B89Q41988630-B434160A-2048-41AE-BDA9-7ED0F259AAAEQ41989676-7A0B42D2-749A-48BF-BA54-767415C4D4F9Q42124356-571142AD-858F-4E28-8327-73C9A5B34300Q42175771-825E9446-6C87-4D89-985F-6AAEFDA3668AQ42219479-9D53EB5A-B3FD-4DC1-AAEB-E843F51278D2Q43090971-A404CBFA-B7B4-4724-937B-BF854B415BA9Q43196665-7D663B3C-2967-48B2-83EE-90B86EB653AEQ44455424-8EBB76E5-CCF2-4691-885B-9AE11311FB3EQ45184671-9DAFB62A-050D-43A7-8905-1D3B7EF08E10Q45953245-13B7E61F-A30B-4C3B-8377-EEC280B9BD4BQ46101248-1F18CDA4-E610-4476-9AFA-31146B73586BQ46704577-D08E37C9-6C33-4456-B7CD-28AF0975E925Q46738080-ABA09FB0-64E2-46BC-89D0-DDE52A08938AQ46762531-85E36718-5434-4499-BDEE-0E5EE1A3996AQ51488103-7CA0BD7D-FFD6-41E2-88DC-29C9A054A056Q51496183-6CD9FDD2-4E85-49DF-94C7-7098BF1FCD75Q54212185-337C7A99-F202-4B5D-900E-32251B9FCDA4Q57343648-120FAB7A-7272-4B56-A86F-75A7E63877F1Q57376812-EF101568-8EAF-4A9B-B893-B77336D60BA7Q57378378-633E5670-AD2C-4DD4-A515-5BEEE044D124Q58602517-A6E43426-998E-42DE-81CB-02A7654986D6Q58749808-73405102-2E9A-401B-8448-3CAC48839413
P2860
Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@ast
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@en
type
label
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@ast
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@en
prefLabel
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@ast
Mechanisms by which cyclodextr ...... lymeric drug delivery systems.
@en
P1476
Mechanisms by which cyclodextr ...... olymeric drug delivery systems
@en
P2093
P356
10.1016/S0378-5173(00)00335-5
P407
P50
P577
2000-03-01T00:00:00Z